3 Distinct businesses
Generic injectables manufacturing and supply in North America, Europe and MENA
Oral and non-injectables generic and specialty branded products manufacturing and supply in the US
Branded generic and in-licensed patented product in MENA
In the US, Hikma 503B provides outsourced sterile compounding services for injectables medicines. Discover more about 503B
670+
Products on the market
32
Manufacturing plants
7
R&D centers worldwide
Related news
Hikma launches Fulvestrant Injection
20 September 2022
Hikma launches Bortezomib for Injection
20 September 2022
Last reviewed on 30 May 2022